speb/financial-data huggingface dataset:
NEOG income_statement (quarterly, 2025-08-31) — Special Income Charges: 76390000.00
NEOG cash_flow (quarterly, 2025-08-31) — Stock Based Compensation: 4962000.00
NEOG balance_sheet (quarterly, 2025-08-31) — Stockholders Equity: 2118649000.00
NEOG balance_sheet (quarterly, 2025-08-31) — Tangible Book Value: -336381000.00
NEOG income_statement (quarterly, 2025-08-31) — Tax Effect Of Unusual Items: 13025778.40
NEOG income_statement (quarterly, 2025-08-31) — Tax Provision: 7470000.00
NEOG income_statement (quarterly, 2025-08-31) — Tax Rate For Calcs: 0.17
NEOG balance_sheet (quarterly, 2025-08-31) — Total Assets: 3378156000.00
NEOG balance_sheet (quarterly, 2025-08-31) — Total Capitalization: 2911179000.00
NEOG balance_sheet (quarterly, 2025-08-31) — Total Debt: 792530000.00
NEOG balance_sheet (quarterly, 2025-08-31) — Total Equity Gross Minority Interest: 2118649000.00
NEOG income_statement (quarterly, 2025-08-31) — Total Expenses: 225280000.00
NEOG balance_sheet (quarterly, 2025-08-31) — Total Liabilities Net Minority Interest: 1259507000.00
NEOG balance_sheet (quarterly, 2025-08-31) — Total Non Current Assets: 2854096000.00
NEOG balance_sheet (quarterly, 2025-08-31) — Total Non Current Liabilities Net Minority Interest: 1113302000.00
NEOG income_statement (quarterly, 2025-08-31) — Total Operating Income As Reported: -16091000.00
NEOG balance_sheet (quarterly, 2025-08-31) — Total Tax Payable: 9449000.00
NEOG income_statement (quarterly, 2025-08-31) — Total Unusual Items: 76390000.00
NEOG income_statement (quarterly, 2025-08-31) — Total Unusual Items Excluding Goodwill: 76390000.00
NEOG balance_sheet (quarterly, 2025-08-31) — Work In Process: 11636000.00
NEOG balance_sheet (quarterly, 2025-08-31) — Working Capital: 377855000.00
NEOG income_statement (quarterly, 2025-11-30) — +Operating Expense: 112061000.00
NEOG income_statement (quarterly, 2025-11-30) — +Total Revenue: 224691000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Accounts Payable: 63040000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Accounts Receivable: 132000000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Additional Paid In Capital: 2611303000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Allowance For Doubtful Accounts Receivable: -3882000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Assets Held For Sale Current: 76756000.00
NEOG income_statement (quarterly, 2025-11-30) — Basic Average Shares: 217525981.00
NEOG income_statement (quarterly, 2025-11-30) — Basic EPS: -0.07
NEOG cash_flow (quarterly, 2025-11-30) — Beginning Cash Position: 138883000.00
NEOG cash_flow (quarterly, 2025-11-30) — Capital Expenditure: -11669000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Capital Lease Obligations: 0.00
NEOG balance_sheet (quarterly, 2025-11-30) — Capital Stock: 34804000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Cash And Cash Equivalents: 145340000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Cash Cash Equivalents And Short Term Investments: 145340000.00
NEOG cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Financing Activities: -451000.00
NEOG cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Investing Activities: -11669000.00
NEOG cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Operating Activities: 19444000.00
NEOG cash_flow (quarterly, 2025-11-30) — Change In Account Payable: -9310000.00
NEOG cash_flow (quarterly, 2025-11-30) — Change In Accrued Expense: 7461000.00
NEOG cash_flow (quarterly, 2025-11-30) — Change In Interest Payable: 7461000.00
NEOG cash_flow (quarterly, 2025-11-30) — Change In Inventory: 18663000.00
NEOG cash_flow (quarterly, 2025-11-30) — Change In Other Working Capital: 1915000.00
NEOG cash_flow (quarterly, 2025-11-30) — Change In Payable: -9310000.00
NEOG cash_flow (quarterly, 2025-11-30) — Change In Payables And Accrued Expense: -1849000.00
NEOG cash_flow (quarterly, 2025-11-30) — Change In Prepaid Assets: -5671000.00
NEOG cash_flow (quarterly, 2025-11-30) — Change In Receivables: -6259000.00
NEOG cash_flow (quarterly, 2025-11-30) — Change In Working Capital: 6799000.00
NEOG cash_flow (quarterly, 2025-11-30) — Changes In Account Receivables: -6259000.00
NEOG cash_flow (quarterly, 2025-11-30) — Changes In Cash: 7324000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Common Stock: 34804000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Common Stock Equity: 2104488000.00
NEOG income_statement (quarterly, 2025-11-30) — Cost Of Revenue: 118007000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Current Accrued Expenses: 11018000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Current Assets: 574576000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Current Deferred Liabilities: 3874000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Current Deferred Revenue: 3874000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Current Liabilities: 147050000.00
NEOG cash_flow (quarterly, 2025-11-30) — Deferred Income Tax: -5400000.00
NEOG cash_flow (quarterly, 2025-11-30) — Deferred Tax: -5400000.00
NEOG cash_flow (quarterly, 2025-11-30) — Depreciation Amortization Depletion: 28927000.00
NEOG cash_flow (quarterly, 2025-11-30) — Depreciation And Amortization: 28927000.00
NEOG income_statement (quarterly, 2025-11-30) — Diluted Average Shares: 217525981.00
NEOG income_statement (quarterly, 2025-11-30) — Diluted EPS: -0.07
NEOG income_statement (quarterly, 2025-11-30) — Diluted NI Availto Com Stockholders: -15924000.00
NEOG income_statement (quarterly, 2025-11-30) — EBIT: -5516000.00
NEOG income_statement (quarterly, 2025-11-30) — EBITDA: 23411000.00
NEOG cash_flow (quarterly, 2025-11-30) — Effect Of Exchange Rate Changes: -867000.00
NEOG cash_flow (quarterly, 2025-11-30) — End Cash Position: 145340000.00
NEOG cash_flow (quarterly, 2025-11-30) — Financing Cash Flow: -451000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Finished Goods: 109007000.00
NEOG cash_flow (quarterly, 2025-11-30) — Free Cash Flow: 7775000.00
NEOG cash_flow (quarterly, 2025-11-30) — Gain Loss On Sale Of Business: 0.00
NEOG cash_flow (quarterly, 2025-11-30) — Gain Loss On Sale Of PPE: 267000.00
NEOG income_statement (quarterly, 2025-11-30) — Gain On Sale Of Business: 0.00
NEOG balance_sheet (quarterly, 2025-11-30) — Gains Losses Not Affecting Retained Earnings: -25609000.00
NEOG income_statement (quarterly, 2025-11-30) — General And Administrative Expense: 65208000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Goodwill: 1046042000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Goodwill And Other Intangible Assets: 2405417000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Gross Accounts Receivable: 135882000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Gross PPE: 347458000.00
NEOG income_statement (quarterly, 2025-11-30) — Gross Profit: 106684000.00
NEOG income_statement (quarterly, 2025-11-30) — Impairment Of Capital Assets: 0.00
NEOG balance_sheet (quarterly, 2025-11-30) — Income Tax Payable: 8963000.00
NEOG income_statement (quarterly, 2025-11-30) — Interest Expense: 14848000.00
NEOG income_statement (quarterly, 2025-11-30) — Interest Expense Non Operating: 14848000.00
NEOG income_statement (quarterly, 2025-11-30) — Interest Income: 592000.00
NEOG income_statement (quarterly, 2025-11-30) — Interest Income Non Operating: 592000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Interest Payable: 11018000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Inventories Adjustments Allowances: -14551000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Inventory: 162766000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Invested Capital: 2897414000.00
NEOG cash_flow (quarterly, 2025-11-30) — Investing Cash Flow: -11669000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Long Term Capital Lease Obligation: 0.00
NEOG balance_sheet (quarterly, 2025-11-30) — Long Term Debt: 792926000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Long Term Debt And Capital Lease Obligation: 792926000.00
NEOG cash_flow (quarterly, 2025-11-30) — Long Term Debt Payments: 0.00
NEOG cash_flow (quarterly, 2025-11-30) — Net Business Purchase And Sale: 0.00
NEOG balance_sheet (quarterly, 2025-11-30) — Net Debt: 647586000.00
NEOG income_statement (quarterly, 2025-11-30) — Net Income: -15924000.00
NEOG income_statement (quarterly, 2025-11-30) — Net Income Common Stockholders: -15924000.00
NEOG income_statement (quarterly, 2025-11-30) — Net Income Continuous Operations: -15924000.00
NEOG income_statement (quarterly, 2025-11-30) — Net Income From Continuing And Discontinued Operation: -15924000.00
NEOG income_statement (quarterly, 2025-11-30) — Net Income From Continuing Operation Net Minority Interest: -15924000.00
NEOG cash_flow (quarterly, 2025-11-30) — Net Income From Continuing Operations: -15924000.00
NEOG income_statement (quarterly, 2025-11-30) — Net Income Including Noncontrolling Interests: -15924000.00
NEOG income_statement (quarterly, 2025-11-30) — Net Interest Income: -14256000.00
NEOG cash_flow (quarterly, 2025-11-30) — Net Investment Purchase And Sale: 0.00
NEOG cash_flow (quarterly, 2025-11-30) — Net Issuance Payments Of Debt: 0.00
NEOG cash_flow (quarterly, 2025-11-30) — Net Long Term Debt Issuance: 0.00
NEOG income_statement (quarterly, 2025-11-30) — Net Non Operating Interest Income Expense: -14256000.00
NEOG cash_flow (quarterly, 2025-11-30) — Net Other Financing Charges: -424000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Net PPE: 347458000.00
NEOG cash_flow (quarterly, 2025-11-30) — Net PPE Purchase And Sale: -11669000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Net Tangible Assets: -300929000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Non Current Deferred Liabilities: 273947000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Non Current Deferred Taxes Liabilities: 273947000.00
NEOG income_statement (quarterly, 2025-11-30) — Normalized EBITDA: 23411000.00
NEOG income_statement (quarterly, 2025-11-30) — Normalized Income: -15924000.00
NEOG cash_flow (quarterly, 2025-11-30) — Operating Cash Flow: 19444000.00
NEOG cash_flow (quarterly, 2025-11-30) — Operating Gains Losses: 267000.00
NEOG income_statement (quarterly, 2025-11-30) — Operating Income: -5377000.00
NEOG income_statement (quarterly, 2025-11-30) — Operating Revenue: 224691000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Ordinary Shares Number: 217525981.00
NEOG balance_sheet (quarterly, 2025-11-30) — Other Current Assets: 57714000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Other Current Liabilities: 39875000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Other Equity Adjustments: -25609000.00
NEOG income_statement (quarterly, 2025-11-30) — Other Gand A: 65208000.00
NEOG income_statement (quarterly, 2025-11-30) — Other Income Expense: -731000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Other Intangible Assets: 1359375000.00
NEOG cash_flow (quarterly, 2025-11-30) — Other Non Cash Items: 437000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Other Non Current Assets: 32502000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Other Non Current Liabilities: 41542000.00
NEOG income_statement (quarterly, 2025-11-30) — Other Non Operating Income Expenses: -731000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Other Properties: 347458000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Payables: 72003000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Payables And Accrued Expenses: 83021000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Pensionand Other Post Retirement Benefit Plans Current: 20280000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Preferred Stock: 0.00
NEOG income_statement (quarterly, 2025-11-30) — Pretax Income: -20364000.00
NEOG cash_flow (quarterly, 2025-11-30) — Proceeds From Stock Option Exercised: -27000.00
NEOG cash_flow (quarterly, 2025-11-30) — Purchase Of PPE: -11669000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Raw Materials: 57631000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Receivables: 132000000.00
NEOG income_statement (quarterly, 2025-11-30) — Reconciled Cost Of Revenue: 118007000.00
NEOG income_statement (quarterly, 2025-11-30) — Reconciled Depreciation: 28927000.00
NEOG cash_flow (quarterly, 2025-11-30) — Repayment Of Debt: 0.00
NEOG income_statement (quarterly, 2025-11-30) — Research And Development: 4563000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Retained Earnings: -516010000.00
NEOG cash_flow (quarterly, 2025-11-30) — Sale Of Business: 0.00
NEOG cash_flow (quarterly, 2025-11-30) — Sale Of Investment: 0.00
NEOG cash_flow (quarterly, 2025-11-30) — Sale Of PPE: 0.00
NEOG income_statement (quarterly, 2025-11-30) — Selling And Marketing Expense: 42290000.00
NEOG income_statement (quarterly, 2025-11-30) — Selling General And Administration: 107498000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Share Issued: 217525981.00
NEOG income_statement (quarterly, 2025-11-30) — Special Income Charges: 0.00
NEOG cash_flow (quarterly, 2025-11-30) — Stock Based Compensation: 4338000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Stockholders Equity: 2104488000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Tangible Book Value: -300929000.00
NEOG income_statement (quarterly, 2025-11-30) — Tax Effect Of Unusual Items: 0.00
NEOG income_statement (quarterly, 2025-11-30) — Tax Provision: -4440000.00
NEOG income_statement (quarterly, 2025-11-30) — Tax Rate For Calcs: 0.22
NEOG balance_sheet (quarterly, 2025-11-30) — Total Assets: 3359953000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Total Capitalization: 2897414000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Total Debt: 792926000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Total Equity Gross Minority Interest: 2104488000.00
NEOG income_statement (quarterly, 2025-11-30) — Total Expenses: 230068000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Total Liabilities Net Minority Interest: 1255465000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Total Non Current Assets: 2785377000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Total Non Current Liabilities Net Minority Interest: 1108415000.00
NEOG income_statement (quarterly, 2025-11-30) — Total Operating Income As Reported: -5377000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Total Tax Payable: 8963000.00
NEOG income_statement (quarterly, 2025-11-30) — Total Unusual Items: 0.00
NEOG income_statement (quarterly, 2025-11-30) — Total Unusual Items Excluding Goodwill: 0.00
NEOG balance_sheet (quarterly, 2025-11-30) — Work In Process: 10679000.00
NEOG balance_sheet (quarterly, 2025-11-30) — Working Capital: 427526000.00
NEOG income_statement (quarterly, 2026-02-28) — +Operating Expense: 102300000.00
NEOG income_statement (quarterly, 2026-02-28) — +Total Revenue: 211200000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Accounts Payable: 75200000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Accounts Receivable: 137100000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Additional Paid In Capital: 2613100000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Allowance For Doubtful Accounts Receivable: -4100000.00
NEOG cash_flow (quarterly, 2026-02-28) — Asset Impairment Charge: 0.00
NEOG balance_sheet (quarterly, 2026-02-28) — Assets Held For Sale Current: 68200000.00
NEOG income_statement (quarterly, 2026-02-28) — Basic Average Shares: 217700000.00
NEOG income_statement (quarterly, 2026-02-28) — Basic EPS: -0.08
NEOG cash_flow (quarterly, 2026-02-28) — Beginning Cash Position: 145340000.00
NEOG cash_flow (quarterly, 2026-02-28) — Capital Expenditure: -11629000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Capital Lease Obligations: 0.00
NEOG balance_sheet (quarterly, 2026-02-28) — Capital Stock: 34800000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Cash And Cash Equivalents: 159900000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Cash Cash Equivalents And Short Term Investments: 159900000.00
NEOG cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Financing Activities: 744000.00
NEOG cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Investing Activities: -11556000.00
NEOG cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Operating Activities: 22703000.00
NEOG cash_flow (quarterly, 2026-02-28) — Change In Account Payable: 15641000.00
NEOG cash_flow (quarterly, 2026-02-28) — Change In Accrued Expense: -7540000.00
NEOG cash_flow (quarterly, 2026-02-28) — Change In Interest Payable: -7540000.00
NEOG cash_flow (quarterly, 2026-02-28) — Change In Inventory: 4795000.00
NEOG cash_flow (quarterly, 2026-02-28) — Change In Other Working Capital: 452000.00
NEOG cash_flow (quarterly, 2026-02-28) — Change In Payable: 15641000.00
NEOG cash_flow (quarterly, 2026-02-28) — Change In Payables And Accrued Expense: 8101000.00
NEOG cash_flow (quarterly, 2026-02-28) — Change In Prepaid Assets: -5568000.00
NEOG cash_flow (quarterly, 2026-02-28) — Change In Receivables: 5252000.00
NEOG cash_flow (quarterly, 2026-02-28) — Change In Working Capital: 13032000.00
NEOG cash_flow (quarterly, 2026-02-28) — Changes In Account Receivables: 5252000.00
NEOG cash_flow (quarterly, 2026-02-28) — Changes In Cash: 11891000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Common Stock: 34800000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Common Stock Equity: 2102400000.00
NEOG income_statement (quarterly, 2026-02-28) — Cost Of Revenue: 112200000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Current Accrued Expenses: 3500000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Current Assets: 590000000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Current Deferred Liabilities: 3900000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Current Deferred Revenue: 3900000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Current Liabilities: 150600000.00
NEOG cash_flow (quarterly, 2026-02-28) — Deferred Income Tax: -4270000.00
NEOG cash_flow (quarterly, 2026-02-28) — Deferred Tax: -4270000.00
NEOG cash_flow (quarterly, 2026-02-28) — Depreciation Amortization Depletion: 28918000.00
NEOG cash_flow (quarterly, 2026-02-28) — Depreciation And Amortization: 28918000.00
NEOG income_statement (quarterly, 2026-02-28) — Diluted Average Shares: 217700000.00
NEOG income_statement (quarterly, 2026-02-28) — Diluted EPS: -0.08
NEOG income_statement (quarterly, 2026-02-28) — Diluted NI Availto Com Stockholders: -17000000.00
NEOG income_statement (quarterly, 2026-02-28) — EBIT: -6400000.00
NEOG income_statement (quarterly, 2026-02-28) — EBITDA: 22518000.00
NEOG cash_flow (quarterly, 2026-02-28) — Effect Of Exchange Rate Changes: 2673000.00
NEOG cash_flow (quarterly, 2026-02-28) — End Cash Position: 159900000.00
NEOG cash_flow (quarterly, 2026-02-28) — Financing Cash Flow: 744000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Finished Goods: 113300000.00
NEOG cash_flow (quarterly, 2026-02-28) — Free Cash Flow: 11074000.00
NEOG cash_flow (quarterly, 2026-02-28) — Gain Loss On Sale Of Business: -10000.00
NEOG cash_flow (quarterly, 2026-02-28) — Gain Loss On Sale Of PPE: 234000.00
NEOG income_statement (quarterly, 2026-02-28) — Gain On Sale Of Business: 0.00
NEOG balance_sheet (quarterly, 2026-02-28) — Gains Losses Not Affecting Retained Earnings: -12500000.00
NEOG income_statement (quarterly, 2026-02-28) — General And Administrative Expense: 60300000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Goodwill: 1047800000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Goodwill And Other Intangible Assets: 2389600000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Gross Accounts Receivable: 141200000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Gross PPE: 347600000.00
NEOG income_statement (quarterly, 2026-02-28) — Gross Profit: 99000000.00
NEOG income_statement (quarterly, 2026-02-28) — Impairment Of Capital Assets: 0.00
NEOG balance_sheet (quarterly, 2026-02-28) — Income Tax Payable: 9900000.00
NEOG income_statement (quarterly, 2026-02-28) — Interest Expense: 13900000.00
NEOG income_statement (quarterly, 2026-02-28) — Interest Expense Non Operating: 13900000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Interest Payable: 3500000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Inventories Adjustments Allowances: -16500000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Inventory: 161700000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Invested Capital: 2895700000.00
NEOG cash_flow (quarterly, 2026-02-28) — Investing Cash Flow: -11556000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Long Term Capital Lease Obligation: 0.00
NEOG balance_sheet (quarterly, 2026-02-28) — Long Term Debt: 793300000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Long Term Debt And Capital Lease Obligation: 793300000.00
NEOG cash_flow (quarterly, 2026-02-28) — Long Term Debt Payments: -25000.00
NEOG cash_flow (quarterly, 2026-02-28) — Net Business Purchase And Sale: -24000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Net Debt: 633400000.00
NEOG income_statement (quarterly, 2026-02-28) — Net Income: -17000000.00
NEOG income_statement (quarterly, 2026-02-28) — Net Income Common Stockholders: -17000000.00
NEOG income_statement (quarterly, 2026-02-28) — Net Income Continuous Operations: -17000000.00
NEOG income_statement (quarterly, 2026-02-28) — Net Income From Continuing And Discontinued Operation: -17000000.00
NEOG income_statement (quarterly, 2026-02-28) — Net Income From Continuing Operation Net Minority Interest: -17000000.00
NEOG cash_flow (quarterly, 2026-02-28) — Net Income From Continuing Operations: -17014000.00
NEOG income_statement (quarterly, 2026-02-28) — Net Income Including Noncontrolling Interests: -17000000.00
NEOG income_statement (quarterly, 2026-02-28) — Net Interest Income: -13900000.00
NEOG cash_flow (quarterly, 2026-02-28) — Net Investment Purchase And Sale: 0.00
NEOG cash_flow (quarterly, 2026-02-28) — Net Issuance Payments Of Debt: -25000.00
NEOG cash_flow (quarterly, 2026-02-28) — Net Long Term Debt Issuance: -25000.00
NEOG income_statement (quarterly, 2026-02-28) — Net Non Operating Interest Income Expense: -13900000.00
NEOG cash_flow (quarterly, 2026-02-28) — Net Other Financing Charges: -53000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Net PPE: 347600000.00
NEOG cash_flow (quarterly, 2026-02-28) — Net PPE Purchase And Sale: -11532000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Net Tangible Assets: -287200000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Non Current Deferred Liabilities: 269200000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Non Current Deferred Taxes Liabilities: 269200000.00
NEOG income_statement (quarterly, 2026-02-28) — Normalized EBITDA: 22518000.00
NEOG income_statement (quarterly, 2026-02-28) — Normalized Income: -17000000.00
NEOG cash_flow (quarterly, 2026-02-28) — Operating Cash Flow: 22703000.00
NEOG cash_flow (quarterly, 2026-02-28) — Operating Gains Losses: 231000.00
NEOG income_statement (quarterly, 2026-02-28) — Operating Income: -3300000.00
NEOG income_statement (quarterly, 2026-02-28) — Operating Revenue: 211200000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Ordinary Shares Number: 217673041.00
NEOG balance_sheet (quarterly, 2026-02-28) — Other Current Assets: 63100000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Other Current Liabilities: 34600000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Other Equity Adjustments: -12500000.00
NEOG income_statement (quarterly, 2026-02-28) — Other Gand A: 60300000.00
NEOG income_statement (quarterly, 2026-02-28) — Other Income Expense: -3100000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Other Intangible Assets: 1341800000.00
NEOG cash_flow (quarterly, 2026-02-28) — Other Non Cash Items: 706000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Other Non Current Assets: 31800000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Other Non Current Liabilities: 43500000.00
NEOG income_statement (quarterly, 2026-02-28) — Other Non Operating Income Expenses: -3100000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Other Properties: 347600000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Payables: 85100000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Payables And Accrued Expenses: 88600000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Pensionand Other Post Retirement Benefit Plans Current: 23500000.00
NEOG income_statement (quarterly, 2026-02-28) — Pretax Income: -20300000.00
NEOG cash_flow (quarterly, 2026-02-28) — Proceeds From Stock Option Exercised: 822000.00
NEOG cash_flow (quarterly, 2026-02-28) — Purchase Of PPE: -11629000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Raw Materials: 55600000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Receivables: 137100000.00
NEOG income_statement (quarterly, 2026-02-28) — Reconciled Cost Of Revenue: 112200000.00
NEOG income_statement (quarterly, 2026-02-28) — Reconciled Depreciation: 28918000.00
NEOG cash_flow (quarterly, 2026-02-28) — Repayment Of Debt: -25000.00
NEOG income_statement (quarterly, 2026-02-28) — Research And Development: 3800000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Retained Earnings: -533000000.00
NEOG cash_flow (quarterly, 2026-02-28) — Sale Of Business: -24000.00
NEOG cash_flow (quarterly, 2026-02-28) — Sale Of Investment: 0.00
NEOG cash_flow (quarterly, 2026-02-28) — Sale Of PPE: 97000.00
NEOG income_statement (quarterly, 2026-02-28) — Selling And Marketing Expense: 38200000.00
NEOG income_statement (quarterly, 2026-02-28) — Selling General And Administration: 98500000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Share Issued: 217673041.00
NEOG income_statement (quarterly, 2026-02-28) — Special Income Charges: 0.00
NEOG cash_flow (quarterly, 2026-02-28) — Stock Based Compensation: 1100000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Stockholders Equity: 2102400000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Tangible Book Value: -287200000.00
NEOG income_statement (quarterly, 2026-02-28) — Tax Effect Of Unusual Items: 0.00
NEOG income_statement (quarterly, 2026-02-28) — Tax Provision: -3300000.00
NEOG income_statement (quarterly, 2026-02-28) — Tax Rate For Calcs: 0.16
NEOG balance_sheet (quarterly, 2026-02-28) — Total Assets: 3359000000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Total Capitalization: 2895700000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Total Debt: 793300000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Total Equity Gross Minority Interest: 2102400000.00
NEOG income_statement (quarterly, 2026-02-28) — Total Expenses: 214500000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Total Liabilities Net Minority Interest: 1256600000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Total Non Current Assets: 2769000000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Total Non Current Liabilities Net Minority Interest: 1106000000.00
NEOG income_statement (quarterly, 2026-02-28) — Total Operating Income As Reported: -3300000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Total Tax Payable: 9900000.00
NEOG income_statement (quarterly, 2026-02-28) — Total Unusual Items: 0.00
NEOG income_statement (quarterly, 2026-02-28) — Total Unusual Items Excluding Goodwill: 0.00
NEOG balance_sheet (quarterly, 2026-02-28) — Work In Process: 9300000.00
NEOG balance_sheet (quarterly, 2026-02-28) — Working Capital: 439400000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -280700000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 2766400000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -2100000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 645300000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 0.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 328000000.00
NEOGEN.NS cash_flow (annual, 2022-03-31) — Common Stock Issuance: 2250000000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 2600000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 0.00
NEOGEN.NS cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: 0.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 119100000.00
NEOGEN.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: 4100000.00
NEOGEN.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: -1100000.00
NEOGEN.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 96100000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 1097100000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Hedging Assets Current: 39100000.00
NEOGEN.NS income_statement (annual, 2022-03-31) — Interest Income: 6000000.00
NEOGEN.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 6000000.00
NEOGEN.NS cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 2250000000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 371100000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 1729300000.00
NEOGEN.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -7700000.00
NEOGEN.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: 1400000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 40400000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 100800000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 1600000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 23700000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: -800000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Other Payable: 79000000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 18700000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 219200000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
NEOGEN.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: -807600000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 391300000.00
NEOGEN.NS income_statement (annual, 2022-03-31) — Research And Development: 47000000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 124200000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 1267800000.00
NEOGEN.NS cash_flow (annual, 2022-03-31) — Sale Of Intangibles: 1700000.00
NEOGEN.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 66300000.00
NEOGEN.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 162400000.00
NEOGEN.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 12800000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 20000000.00
NEOGEN.NS balance_sheet (annual, 2022-03-31) — Work In Process: 1411800000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — +Operating Expense: 1582200000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — +Total Revenue: 6604800000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 1565500000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 1773800000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -417000000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 2766400000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -9000000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Amortization: 3000000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 82200000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 24939316.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Basic EPS: 20.03
NEOGEN.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 452200000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 782100000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -1037400000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 73000000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 249400000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 182200000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 967600000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -68600000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 0.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 182200000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -983800000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -300700000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 63300000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Change In Payable: 532000000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -669800000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -1359000000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -245200000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Common Stock: 249400000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 4825200000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 358400000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 4068400000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Current Assets: 6558300000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 22700000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Current Debt: 2331300000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 2354000000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 17600000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 4097400000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 20800000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Depreciation: 162000000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 162000000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 162000000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 159000000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 24939316.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Diluted EPS: 20.03
NEOGEN.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 499700000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 0.00
NEOGEN.NS income_statement (annual, 2023-03-31) — EBIT: 947300000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — EBITDA: 1109300000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 0.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — End Cash Position: 207000000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Financial Assets: 0.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 1002900000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 588900000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -1340900000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -44200000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 0.00
NEOGEN.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 104700000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 14100000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 1782700000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 4235900000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Gross Profit: 2536400000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Hedging Assets Current: -1400000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Interest Expense: 237000000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 237000000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Interest Income: 38300000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 38300000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -289400000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 44200000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Inventory: 2929700000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 8447300000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -944600000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 82200000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Investmentsin Joint Venturesat Cost: 7500000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 2260800000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 371100000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 50300000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 1290800000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 1341100000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 2260800000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -899900000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 7500000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 46500000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 2241000000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Net Debt: 3439900000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 50100000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Net Income: 499700000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 499700000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 499700000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 499700000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 499700000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 710300000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 499700000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -12500000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Net Interest Income: -251100000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 47000000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 1360900000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 1360900000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -251100000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 37500000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Net PPE: 3818900000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -1024900000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 4811100000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Non Current Accrued Expenses: 0.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 0.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 190200000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 46500000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 139300000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 1109300000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Normalized Income: 499700000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: -303500000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Operating Income: 954200000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Operating Revenue: 6604800000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 24939316.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: -100000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 15400000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 4575800000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 14100000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 55400000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 289400000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -100000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: -900000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 6200000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 702200000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Other Payable: 136900000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Other Properties: 483300000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 340700000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 785400000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Payables: 1720000000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 20800000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 547900000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Pretax Income: 710300000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 3100000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: -12500000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -1024900000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 376000000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 4068400000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 162000000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 29900000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 29900000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -899900000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Research And Development: 47000000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 0.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 1699800000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Sale Of Business: 0.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 47000000.00
NEOGEN.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 0.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 202700000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 307400000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Share Issued: 24939316.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 4825200000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 4811100000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Tax Provision: 210600000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.30
NEOGEN.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -115200000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Total Assets: 10538000000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 6116000000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Total Debt: 3695100000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 4825200000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Total Expenses: 5650600000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 5712800000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 3979700000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 1615400000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 52400000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 17600000.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 0.00
NEOGEN.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 0.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Tradeand Other Payables Non Current: 20000000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Work In Process: 1909400000.00
NEOGEN.NS balance_sheet (annual, 2023-03-31) — Working Capital: 2460900000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — +Operating Expense: 1795600000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — +Total Revenue: 6708300000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1446000000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 2816900000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -641400000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 5219800000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Amortization: 2800000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 2800000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 4800000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 25540299.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Basic EPS: 13.96
NEOGEN.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 207000000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 838000000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -3027700000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 153900000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 263800000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 122300000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 152800000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -74800000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 122300000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -894700000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 210300000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 943700000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Change In Payable: -108900000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -1438000000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -1287600000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -82000000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Common Stock: 263800000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 7602900000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 2466500000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 1089100000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 4040800000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Current Assets: 7836600000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 19400000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Current Debt: 2693000000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 2712400000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 34600000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 5269700000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 13100000.00